MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer

2004-11-01

Additional Metadata
Keywords	Contrast agent, Magnetic resonance imaging, Microvascular permeability, Therapy, Tumor angiogenesis
Persistent URL	doi.org/10.1002/jmri.20184, hdl.handle.net/1765/61345
Journal	Journal of Magnetic Resonance Imaging
Organisation	Department of Radiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Preda, A., Novikov, V., Möglich, M., Turetschek, K., Shames, D., Brasch, R., … Roberts, T. P. (2004). MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer. Journal of Magnetic Resonance Imaging, 20(5), 865–873. doi:10.1002/jmri.20184

Publication